Modulation of Macrophage Responsiveness to Lipopolysaccharide by IRAK-1 Manipulation
暂无分享,去创建一个
R. Maier | J. Cuschieri | P. Stayton | V. Bulmus | D. Gourlay | I. García | A. Hoffman
[1] S. Foster,et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid , 2003, Nature Immunology.
[2] C. Coopersmith,et al. Antibiotics Improve Survival and Alter the Inflammatory Profile in a Murine Model of Sepsis From Pseudomonas aeruginosa Pneumonia , 2003, Shock.
[3] A. Hoffman,et al. Affinity thermoprecipitation and recovery of biotinylated biomolecules via a mutant streptavidin-smart polymer conjugate. , 2003, Bioconjugate chemistry.
[4] D. Mannino,et al. The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.
[5] A. Al-ghonaium,et al. Pyogenic Bacterial Infections in Humans with IRAK-4 Deficiency , 2003, Science.
[6] Sophie Janssens,et al. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. , 2003, Molecular cell.
[7] S. Opal,et al. Endotoxin as a drug target , 2003, Critical care medicine.
[8] F. Cunha,et al. A Critical Role of Leukotriene B4 in Neutrophil Migration to Infectious Focus in Cecal Ligation and Puncture Sepsis , 2003, Shock.
[9] M. Holmes,et al. Neutrophil Modulation of the Pulmonary Chemokine Response to Lipopolysaccharide , 2002, Shock.
[10] M. Lamy,et al. Bronchoalveolar lavage fluids of patients with lung injury activate the transcription factor nuclear factor-kappaB in an alveolar cell line. , 2002, Clinical science.
[11] J. Siddiqui,et al. Six at Six: Interleukin-6 Measured 6 H After the Initiation of Sepsis Predicts Mortality Over 3 Days , 2002, Shock.
[12] H. Gerlach,et al. Clinical implications of antibiotic-induced endotoxin release in septic shock , 2002, Intensive Care Medicine.
[13] T. Mak,et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4 , 2002, Nature.
[14] K. Reinhart,et al. Platelet and Leukocyte Activation Correlate with the Severity of Septic Organ Dysfunction , 2002, Shock.
[15] L. Moldawer,et al. SEPSIS SYNDROMES: UNDERSTANDING THE ROLE OF INNATE AND ACQUIRED IMMUNITY , 2001, Shock.
[16] G. Clermont,et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.
[17] S. Akira,et al. CD11b/CD18 Acts in Concert with CD14 and Toll-Like Receptor (TLR) 4 to Elicit Full Lipopolysaccharide and Taxol-Inducible Gene Expression1 2 3 , 2001, The Journal of Immunology.
[18] T. Calandra. Pathogenesis of Septic Shock: Implications for Prevention and Treatment , 2001, Journal of chemotherapy.
[19] A. Hall,et al. Lipopolysaccharide-Induced Activation of β2-Integrin Function in Macrophages Requires Irak Kinase Activity, p38 Mitogen- Activated Protein Kinase, and the Rap1 GTPase , 2001, Molecular and Cellular Biology.
[20] S. Akira,et al. Toll-like receptors and their signaling mechanism in innate immunity , 2001, Acta odontologica Scandinavica.
[21] S. Akira,et al. Synergy and Cross-Tolerance Between Toll-Like Receptor (TLR) 2- and TLR4-Mediated Signaling Pathways1 , 2000, The Journal of Immunology.
[22] R. Dziarski,et al. Role of MD-2 in TLR2- and TLR4-mediated recognition of Gram-negative and Gram-positive bacteria and activation of chemokine genes. , 2000, Journal of endotoxin research.
[23] W. Mileski,et al. Stat proteins play a role in tumor necrosis factor alpha gene expression. , 2000, Shock.
[24] C. Haslett,et al. Pulmonary endothelial permeability and circulating neutrophil-endothelial markers in patients undergoing esophagogastrectomy , 2000, Critical care medicine.
[25] S. Akira,et al. Immune Cell Activation by Bacterial Cpg-DNA through Myeloid Differentiation Marker 88 and Tumor Necrosis Factor Receptor–Associated Factor (Traf)6 , 2000, The Journal of experimental medicine.
[26] M. Lamy,et al. Correlation between endotoxin level and bacterial count in bronchoalveolar lavage fluid of ventilated patients , 2000, Critical care medicine.
[27] S. Vogel,et al. Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 21 , 2000, The Journal of Immunology.
[28] S. Opal,et al. The role of interleukin-10 in critical illness. , 2000, Current opinion in infectious diseases.
[29] J. Bertrand,et al. Endotoxaemia in patients with severe sepsis or septic shock , 2000, Intensive Care Medicine.
[30] J. Swantek,et al. IL-1 Receptor-Associated Kinase Modulates Host Responsiveness to Endotoxin1 , 2000, The Journal of Immunology.
[31] L. Moldawer,et al. Cytokine signaling--regulation of the immune response in normal and critically ill states. , 2000, Critical care medicine.
[32] A. Simpson,et al. Differential antibiotic-induced endotoxin release in severe melioidosis. , 2000, The Journal of infectious diseases.
[33] A. Ridley,et al. Lipopolysaccharide Induces Actin Reorganization and Tyrosine Phosphorylation of Pyk2 and Paxillin in Monocytes and Macrophages1 , 2000, The Journal of Immunology.
[34] I. Chaudry,et al. What is the role of interleukin 10 in polymicrobial sepsis: anti-inflammatory agent or immunosuppressant? , 1999, Surgery.
[35] S. Deventer,et al. CYTOKINES AND ANTICYTOKINES IN THE PATHOGENESIS OF SEPSIS , 1999 .
[36] M. Rothe,et al. Bacterial Lipopolysaccharide Activates Nuclear Factor-κB through Interleukin-1 Signaling Mediators in Cultured Human Dermal Endothelial Cells and Mononuclear Phagocytes* , 1999, The Journal of Biological Chemistry.
[37] D. Remick,et al. ANTIBIOTIC TREATMENT INFLUENCES OUTCOME IN MURINE SEPSIS: MEDIATORS OF INCREASED MORBIDITY , 1998, Shock.
[38] R. Holzheimer. The significance of endotoxin release in experimental and clinical sepsis in surgical patients — Evidence for antibiotic-induced endotoxin release? , 1998, Infection.
[39] J. Peterson,et al. Bacterial lipoprotein and lipopolysaccharide act synergistically to induce lethal shock and proinflammatory cytokine production. , 1997, Journal of immunology.
[40] Douglas K. Miller,et al. The Interleukin-1 Receptor-associated Kinase Is Degraded by Proteasomes following Its Phosphorylation* , 1997, The Journal of Biological Chemistry.
[41] L. Casey. Antibiotics: more than just "bug" killers. , 1997, Critical care medicine.
[42] W. van Oeveren,et al. Effect of intraperitoneal antimicrobials on the concentration of bacteria, endotoxin, and tumor necrosis factor in abdominal fluid and plasma in rats. , 1996, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.
[43] M. Schein,et al. Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparotomy for severe secondary peritonitis. , 1995, Archives of surgery.
[44] C. Sprung,et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. , 1995, Critical care medicine.
[45] F Doyon,et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. , 1995, JAMA.
[46] E. Kuijper,et al. Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. , 1995, The Journal of infectious diseases.
[47] S. Deventer,et al. Clinical relevance of antibiotic-induced endotoxin release , 1994, Antimicrobial Agents and Chemotherapy.
[48] R. Bone,et al. Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome , 1993, Annals of Internal Medicine.
[49] R. Eng,et al. Effect of antibiotics on endotoxin release from gram-negative bacteria. , 1993, Diagnostic microbiology and infectious disease.
[50] J. Jackson,et al. beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. , 1992, The Journal of infectious diseases.
[51] S. Lowry,et al. Tumor necrosis factor in the pathophysiology of infection and sepsis. , 1990, Clinical immunology and immunopathology.
[52] M. Lamy,et al. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. , 1989, Critical care medicine.
[53] P. Brandtzaeg,et al. Brief Definitive Report the Complex Pattern of Cytokines in Serum from Patients with Meningococcal Septic Shock Association between Interleukin 6, Interleukin 1, and Fatal Outcome , 2022 .
[54] R. Ulevitch,et al. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. , 1988, The Journal of clinical investigation.
[55] A. Waage,et al. ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE , 1987, The Lancet.
[56] B. Meyrick,et al. Endotoxin and lung injury. , 1986, The American review of respiratory disease.
[57] R. Roeder,et al. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.
[58] I. Magrath,et al. Acute tumor lysis syndrome: A review of 37 patients with Burkitt's lymphoma , 1980 .
[59] S. Bucklin,et al. Differential antibiotic-induced release of endotoxin from gram-negative bacteria , 2006, European Journal of Clinical Microbiology and Infectious Diseases.
[60] F. Squadrito,et al. Effect of cross-tolerance between endotoxin and TNF-alpha or IL-1beta on cellular signaling and mediator production. , 2001, Journal of leukocyte biology.
[61] F. Guo,et al. Antisense IRAK-1 oligonucleotide blocks activation of NF-kappa B and AP-1 induced by IL-18. , 2000, Immunopharmacology.
[62] W. Summer,et al. Serine/threonine phosphorylation in cellular signaling for alveolar macrophage phagocytic response to endotoxin. , 2000, Shock.
[63] M. Fink. Surgical infections: blocking the mediator cascade responsible for sepsis and septic shock. , 1993, Current opinion in general surgery.